In this week’s edition of InnovationRx, we look at Phil Knight’s big cancer gift, Medallion’s credentialing clearinghouse, a ...

NeuroOne stock rallies after FDA clears its OneRF system, a minimally invasive solution targeting severe facial pain, scheduled to launch in late 2025.

NeuroOne Medical Technologies has obtained 510(k) clearance from the US Food and Drug Administration (FDA) for its OneRF ...

Neuroone Medical Technologies Corp. expanded into treatment of chronic pain with a new U.S. FDA clearance for use of its Onerf system to treat trigeminal nerve pain. The system uses radiofrequency ...

Trigeminal nerve ablation, a minimally invasive procedure, uses RF energy to destroy abnormal tissue and relieve severe, ...

NeuroOne Medical Technologies ( ($NMTC) ) has provided an announcement. On August 18, 2025, NeuroOne Medical Technologies Corporation announced it ...

Technologies has received U.S. Food and Drug Administration, FDA, clearance to market its OneRF Trigeminal Nerve Ablation ...

NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) Q3 2025 Earnings Call Transcript August 14, 2025 NeuroOne Medical Technologies Corporation beats earnings expectations. Reported EPS is $-0.03, ...

NeuroOne Medical Technologies(NASDAQ:NMTC) reported fiscal third quarter 2025 earnings on August 14, 2025, with product revenue up 105% year-over-year to $1.7 million and product gross margins rising ...

Ronald W. McClurg, CFO, said, "product revenue increased 105% to $1.7 million" and cited "sizable improvements year-over-year ...

Discover insights from NeuroOne Medical Technologies (NMTC)'s Q3 2025 earnings call, featuring 105% revenue growth, new clinical milestones, and ...